---
name: J2.3 Short-Term Follow-up After Treatment for Histologic HSIL 

externalData:
- resources

data:
- 
  resourceType: Patient
  name: Joanne Smith
  gender: female
  birthDate: 1991-01-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F
-
  $iterate: *HistologicHSIL2YearsAgo
- 
  $iterate: *HasTreatment2YearsAgo
- 
  resourceType: DiagnosticReport
  code: LOINC#21440-3 Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
  status: final
  conclusionCode:
  - SNOMEDCT#708298003 Deoxyribonucleic acid of Human papillomavirus 16 (substance)
  effectiveDateTime: 2020-05-01
-
  $iterate: *HistologicHSILThisYear

results:
  Recommendation: 
    short: 'See Details'
    date: '2021-06-02'
    group: 'Management Surveillance (J.2.3)'
    details:
    - 'If recurrent histologic HSIL (CIN 2+) develops after excisional treatment, and repeat excision is not feasible or not desired, hysterectomy is recommended.'
  WhichRarityMadeTheRecommendation: 4